Search

Your search keyword '"Silberstein, Peter"' showing total 558 results
Start Over Author "Silberstein, Peter"
558 results on '"Silberstein, Peter"'

5. Demographic insights in systemic EBV-positive T-cell lymphoproliferative disease of childhood: A comprehensive NCDB analysis.

Author

Abi Karam, Karam Rabih, primary, Demangone, Michael, additional, Grover, Jasika, additional, Lee, Daniel, additional, Venkatesan, Sharanya, additional, Dieu, Alexandria, additional, Hsia, Beau, additional, Langland, Dylan, additional, Cronen, Austin, additional, Heise, Craig, additional, and Silberstein, Peter T., additional

Published
2024
Full Text
View/download PDF

6. Demographics and socioeconomic factors of adenocarcinoma with apocrine metaplasia.

Author

Puvvadi, Suraj, primary, Nowlen, Frances, additional, Tran, Daniel, additional, Callas, Bradley, additional, Chin, Kat, additional, Sadighian, Sadaf, additional, Loken, Delaney, additional, Silberstein, Peter T., additional, Lee, Daniel, additional, Demangone, Michael, additional, Rossi, Anthony, additional, Heise, Craig, additional, and Hsia, Beau, additional

Published
2024
Full Text
View/download PDF

12. The epidemiology and demographic statistics of serrated adenocarcinoma.

Author

Chin, Kat, primary, Choe, Sharon, additional, Grover, Jasika, additional, Harirchian, Shervin, additional, Nguyen, Jacqueline, additional, Gonzalez, Karissa, additional, Loken, Delaney, additional, Silberstein, Peter T., additional, Lee, Daniel, additional, Demangone, Michael, additional, Rossi, Anthony, additional, Heise, Craig, additional, and Hsia, Beau, additional

Published
2024
Full Text
View/download PDF

26. Comparison of disease‐specific survival in penile melanoma versus other cutaneous sites: a SEER national database study.

Author

Choe, Sharon I., Taylor, Mitchell A., Griffin, Julia B., and Silberstein, Peter T.

Subjects
MUCOUS membranes, PENILE cancer, INCOME, ALASKA Natives, DELAYED diagnosis, MELANOMA
Abstract

The study compared disease-specific survival rates between primary penile melanoma (PPM) and melanoma in other cutaneous sites using the SEER database. PPM patients had higher rates of regional and distant stages of disease, tumor ulceration, and thicker Breslow depths compared to other sites. Univariate analysis showed that PPM had significantly poorer disease-specific survival rates, with a multivariate analysis indicating a higher risk of disease-specific mortality for PPM patients. The study highlights the need for early detection and education on melanoma in atypical sites to improve outcomes for PPM patients. [Extracted from the article]

Published
2024
Full Text
View/download PDF

41. Patterns of Palliative Treatments in Stage IV Esophageal Cancer.

Author

Cichon, Gregory J., Betts, Lucas J., McKillip, Kathleen M., and Silberstein, Peter T.

Abstract

Background: The 5 year survival rate of esophageal cancer is under 20%. Studies have shown that early palliative treatments can improve patient quality of life and lower depressed mood without expediting mortality. Despite these benefits, few studies have analyzed factors associated with the national variation among patients who received palliative treatment for esophageal cancer. Methods: This is a retrospective study of adults diagnosed with stage IV esophageal cancer between 2004 and 2018 in the National Cancer Database (NCDB) who received palliative treatment or not (n = 43,599). Cross tabulation and binary logistic regression were performed and evaluated using SPSS. Exclusion criteria included concurrent tumors, patients under age 18, and missing data. Results: Of the 43,599 patients, 26.1% of patients received palliative interventions (n = 11,371). The majority of palliative treatment patients lived less than 6 months after diagnosis (54%) and received radiation (35.7%) or chemotherapy (34.5%) with palliative intent. The patients who received palliative treatment tended to be non-Hispanic (96.6%), white (87.2%), male (83.3%) patients between age 61 and 75 (43.8%) at a comprehensive community cancer program (38.7%) with adenocarcinoma histology (71.8%). Palliative treatment patients most commonly relied on Medicare as their primary payor (45.9%) and had a median household income over $48,000 (54.5%). Conclusion: We identified trends among stage IV esophageal cancer patients receiving palliative treatments. Patients receiving palliative treatments tended to be white, non-Hispanic men. Compared to patients who did not receive palliating treatments, this cohort was more likely to receive treatment at a comprehensive, academic, or integrated network facility. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

49. Tables S1-S9 and Figures S1-S5 from Analysis of the CDKN2A Gene in FAMMM Syndrome Families Reveals Early Age of Onset for Additional Syndromic Cancers

Author

Middlebrooks, Candace D., primary, Stacey, Mark L., primary, Li, Qing, primary, Snyder, Carrie, primary, Shaw, Trudy G., primary, Richardson-Nelson, Tami, primary, Rendell, Marc, primary, Ferguson, Claire, primary, Silberstein, Peter, primary, Casey, Murray J., primary, Bailey-Wilson, Joan E., primary, and Lynch, Henry T., primary

Published
2023
Full Text
View/download PDF

50. Data from Analysis of the CDKN2A Gene in FAMMM Syndrome Families Reveals Early Age of Onset for Additional Syndromic Cancers

Author

Middlebrooks, Candace D., primary, Stacey, Mark L., primary, Li, Qing, primary, Snyder, Carrie, primary, Shaw, Trudy G., primary, Richardson-Nelson, Tami, primary, Rendell, Marc, primary, Ferguson, Claire, primary, Silberstein, Peter, primary, Casey, Murray J., primary, Bailey-Wilson, Joan E., primary, and Lynch, Henry T., primary

Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results